UPDATE 1-Mylan says merger with Teva would be bad fit

April 17, 2015 7:31 PM

2 0

April 17 (Reuters) - Generic drugmaker Mylan NV moved quickly on Friday to pour cold water on published reports that Teva Pharmaceuticals Industries is considering a bid to acquire it.

Mylan last week announced a $29 billion offer to buy Perrigo Co Plc in a move that some analysts suggested was a tactic to help fend off an acquisition by larger rival Teva.

Also read: Dow gains 100 points amid deluge of corporate news; real estate leads

Read more

To category page